JSR Corp (4185):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:JSR Corp (4185) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9901
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
JSR Corp (JSR), formerly Japan Synthetic Rubber Co Ltd is a chemical manufacturing company. It produces a synthetic rubbers, emulsions and plastics. The company, along with its subsidiaries, provides general-purpose synthetic rubbers, special purpose synthetic rubbers, thermoplastic elastomer (TPE) and various other related products. The company also develops semiconductor materials, optical materials, display materials, emulsion products and performance chemicals for information and communication industries through its proprietary polymer technologies. In addition, JSR manufactures synthetic resins including ABS resins, AES resins, AS resins, and ASA resins. Geographically, the company operates across the US, Singapore, Thailand, China, Germany, Belgium and Hong Kong among others. JSR is headquartered in Minato-Ku, Tokyo, Japan.

JSR Corp (4185) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JSR Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JSR Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JSR Corp, Medical Devices Deals, 2012 to YTD 2018 9
JSR Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JSR Corp, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
KBI Biopharma Acquires Assets of Elion Labs 12
KBI Biopharma Acquires Manufacturing and Laboratory Assets of Opexa Therapeutics 13
KBI Biopharma To Acquire Biologics Operations Of Merck 14
Venture Financing 15
ReForm Biologics Raises Funds through Venture Financing 15
GlycoSeLect Raises USD0.5 Million in Seed Round of Financing 16
Aeglea BioTherapeutics Raises Additional USD1 Million in Series A Venture Financing 17
Partnerships 18
ReForm Biologics Enters into Agreement with KBI Biopharma 18
JSR Enters Into Co-Development Agreement With BIA Separations For Purification Technology 19
Licensing Agreements 20
JSR Enters into Licensing Agreement with Keio University 20
BiomX Enters into Licensing Agreement with JSR 21
Vedanta Biosciences Enters into Licensing Agreement with JSR Corp 22
Equity Offering 23
Coherus Biosciences Raises USD6.8 Million in Private Placement of Shares 23
Acquisition 24
JSR Acquires Crown Bioscience for USD399.7 Million 24
KBI Biopharma to Acquire Alliance Protein Labs 26
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 27
JSR to Acquire Stake in Medical & Biological Lab 28
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 29
JSR Acquires Minority Stake In Scivax Life Sciences 30
JSR Corp – Key Competitors 31
JSR Corp – Key Employees 32
JSR Corp – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
JSR Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JSR Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JSR Corp, Deals By Therapy Area, 2012 to YTD 2018 8
JSR Corp, Medical Devices Deals, 2012 to YTD 2018 9
JSR Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KBI Biopharma Acquires Assets of Elion Labs 12
KBI Biopharma Acquires Manufacturing and Laboratory Assets of Opexa Therapeutics 13
KBI Biopharma To Acquire Biologics Operations Of Merck 14
ReForm Biologics Raises Funds through Venture Financing 15
GlycoSeLect Raises USD0.5 Million in Seed Round of Financing 16
Aeglea BioTherapeutics Raises Additional USD1 Million in Series A Venture Financing 17
ReForm Biologics Enters into Agreement with KBI Biopharma 18
JSR Enters Into Co-Development Agreement With BIA Separations For Purification Technology 19
JSR Enters into Licensing Agreement with Keio University 20
BiomX Enters into Licensing Agreement with JSR 21
Vedanta Biosciences Enters into Licensing Agreement with JSR Corp 22
Coherus Biosciences Raises USD6.8 Million in Private Placement of Shares 23
JSR Acquires Crown Bioscience for USD399.7 Million 24
KBI Biopharma to Acquire Alliance Protein Labs 26
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 27
JSR to Acquire Stake in Medical & Biological Lab 28
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 29
JSR Acquires Minority Stake In Scivax Life Sciences 30
JSR Corp, Key Competitors 31
JSR Corp, Key Employees 32
JSR Corp, Other Locations 34
JSR Corp, Subsidiaries 34
JSR Corp, Joint Venture 35

List of Figures
JSR Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JSR Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JSR Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JSR Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[JSR Corp (4185):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Helomics Corp-医療機器分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • First Solar, Inc.:企業の戦略・SWOT・財務情報
    First Solar, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Solar, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Allegion Plc:企業の戦略・SWOT・財務情報
    Allegion Plc - Strategy, SWOT and Corporate Finance Report Summary Allegion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kwality Group
    Kwality Group - Strategy, SWOT and Corporate Finance Report Summary Kwality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CeQur SA:医療機器:M&Aディール及び事業提携情報
    Summary CeQur SA (CeQur) is a medical device company that develops and commercializes insulin delivery systems. The company offers product PAQ, a wearable insulin delivery device, which delivers both basal and bolus doses. Its PAQ product consist two components such as insulin reservoir and messenge …
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務情報
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • NWF Group plc (NWF):企業の財務・戦略的SWOT分析
    Summary NWF Group Plc (NWF) is a consumer goods company that offers animal feedstuffs products. The company operates through feeds, food and fuel segments. It offers products such as fuel oil, dairy products, animal feeds and agricultural products. Its offers fuel, food and feed business solutions. …
  • Mediacom Communications Corporation:企業の戦略的SWOT分析
    Mediacom Communications Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SunOpta Inc.:企業の戦略・SWOT・財務情報
    SunOpta Inc. - Strategy, SWOT and Corporate Finance Report Summary SunOpta Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Amdocs Ltd (DOX):企業の財務・戦略的SWOT分析
    Amdocs Ltd (DOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • CryoTherapeutics Gmbh-医療機器分野:企業M&A・提携分析
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company’s proprietary cryotherapy system is used for the treatment of coronary artery disease that causes heart attacks. …
  • Black Stone Minerals LP (BSM):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Stone Minerals LP (Black Stone) is a mining and minerals exploration and development company that explores and produces mineral deposits. The company's services include participating on a working interest basis when economics are favorable, leasing minerals to exploration and productio …
  • Callon Petroleum Co (CPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exploration, and exploitation of unconventional onshore, oil, and natural gas reserves. It operates …
  • TrialBee AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TrialBee AB (TrialBee) is a provider of innovative software solutions that accelerates clinical trials. The company provides services such as online patient recruitment, online study feasibility, study retention and electronic data capture, among others. It offers cloud based solution which …
  • CD Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CD Diagnostics Inc (CD Diagnostics), a subsidiary of Zimmer Biomet Holdings Inc, is a diagnostics company that develops immunoassays to improve patient outcomes. The company provides synovascure analytical tools. Its products are used in alpha defenses, CRP, hemoglobin tests, incubation of a …
  • Guardant Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Globeimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • ARMZ Uranium Holding Co:企業の戦略的SWOT分析
    ARMZ Uranium Holding Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Ausenco Ltd:企業の戦略・SWOT・財務情報
    Ausenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Ausenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆